Indian Overseas Bank (IOB) Q2 Results FY27 Preview: Date, Time, Expectations & Key Things To Watch

Indian Overseas Bank, a Government-owned lender with a 92.44% GoI stake as of June 30, 2026, has been posting a steady run of improving profitability, with net profit rising for eleven straight quarters. The Q2 FY 2026-2027 print will speak to whether global NIM holds the 3.30-3.40% guided band through the rate cycle and how the bank's cost line normalises after Q1's employee-cost spike pushed cost-to-income to 53.95%.

Indian Overseas Bank Q2 Results Date and Time

The Board of Indian Overseas Bank will meet on October 26, 2026 to consider the audited financial results for the quarter and half year ended September 30, 2026 (Q2 FY 2026-2027).

What to expect from Indian Overseas Bank's Q2 FY27 results

The quarter's central test is whether IOB's margin and cost discipline holds: global NIM entered at 3.37% against a 3.30-3.40% guided band, while Q1's employee-cost spike (+80.41% YoY) pushed cost-to-income to 53.95% versus the ~42% target, making cost normalisation the margin bridge to watch. Inside the July-September window, fresh deposit costs fell (WADTDR-fresh 5.85% to 5.67% from July to August) and the repo rate stayed unchanged at 5.25%, supporting management's 'no increase in cost of deposits' call; the repo hike to 5.50% landed only in October, so its effect on the 37% RLLR-linked book is a Q3 question. Growth momentum remains well ahead of guidance, with advances up 22.75% YoY and deposits up 13.72% YoY at Jun-26 against a 13-14% minimum guide, and RAM advances up 35.82%. Asset quality entered at its best on record — GNPA 1.33%, NNPA 0.18%, PCR 97.67% and slippage ratio 0.06% — with credit cost of 0.14% in Q1 against the 0.35-0.40% FY27 guide. The corporate book rebuild after Q1's exit of a single ~Rs. 10,000 Cr account, backed by a Rs. 14,000 Cr sanctioned pipeline, is the company-specific swing factor for the print. The upcoming call is likely to cover the NIM bridge, the ECL provisioning glide path (Rs. 2,150 Cr held at Jun-26 versus a >Rs. 3,000 Cr target by April 2027) and capital-raise execution following the October 20 SEBI approval of an ESPS issue of up to 10 crore shares.

Key Things To Watch

Guidance scorecard tracking into Q2 FY27: Where the bank stands against its own stated targets heading into the print.

• Credit growth — 13-14% (minimum) for FY27 — tracking +22.75% YoY at Jun-26
• NIM (global) — 3.3-3.40% open-ended — 3.37% at Jun-26; ROA — ~1.3% FY27 — 1.41% at Jun-26
• ECL provisions — >Rs. 3,000 Cr by Apr 2027 — Rs. 2,150 Cr held at Jun-26; recoveries — ~Rs. 3,600 Cr FY27 — Rs. 654 Cr in Q1 FY27
• Equity raise — Rs. 5,000 Cr in Q3/Q4 FY27 — ESPS approved Oct 20; statutory approvals stage

NIM through the rate cycle: Rate revisions landed after the quarter window, but the margin path is the live question.

• RLLR raised 25 bps to 8.35% effective Oct 8 and one-year MCLR cumulatively +10 bps to 8.90%, with 54% of the credit portfolio MCLR-linked and 37% RLLR-linked
• Watch whether global NIM holds the 3.3-3.4% band and whether the 'no increase in cost of deposits' call survives; CASA ratio was 41.45% domestic at Jun-26 with bulk deposits restricted to 6-7%

Corporate book rebuild: Q1 saw a sharp corporate-book decline from a single-account exit.

• Q1 saw a 10% QoQ decline from exiting a single ~Rs. 10,000 Cr account in April (pricing not competitive; ~40% of the impact covered in Q1)
• A Rs. 14,000 Cr sanctioned pipeline and 12-13% corporate growth expected by year-end — verify the rebuild pace and pricing discipline (no sub-7% corporate lending)

Asset quality and recovery run-rate: Entry asset quality is the best on record; the watch is on whether it stays contained.

• SMA-2 at Rs. 4,246 Cr (+Rs. 500 Cr QoQ at Jun-26); whether GNPA extends below 1.33% and slippage stays near 0.06%
• Recovery run-rate of Rs. 654 Cr in Q1 against the moderated Rs. 3,600 Cr FY27 target; FY26's Rs. 4,000 Cr aim was missed at ~Rs. 3,700 Cr
• Overseas GNPA of 8.5% with resolution dependent on local court processes and no definite timeline

Fee-income lumpiness and capital raise execution: Two items analysts have repeatedly probed.

• PSLC commission swung from Rs. 48 Cr in Mar-26 to Rs. 863 crores in Q1 FY27; sustainability questioning is likely to recur
• Whether the Rs. 5,000 crores equity raise (tranches in Q3/Q4 FY27) and the ESPS route of up to 10 crore shares progress, and how the ESPS issuance interacts with the earlier QIP framing